Injections of Botulinum Toxin A in Treatment of Patients With Detrusor Overactivity and Impaired Contractility
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The objectives of this study is to evaluate and compare the efficacy and safety between 100 U
of botulinum toxin A (BoNT-A) suburothelial injections and combined 50 U of BoNT-A
suburothelial injections and 50 U urethral injection for the treatment of detrusor
overactivity and inadequate contractility (DHIC) refractory to antimuscarinic agents
Phase:
Phase 2
Details
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA